Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
AMD Severity ScaleAstigmatism AssistantBarrett / SRK-T SimDiabetic Retinopathy RiskGlaucoma ProgressionGlaucoma Risk (OHTS)Graves CASHFA MD to VFI ConverterIOP Correction (CCT)LogMAR <-> SnellenMRD AssessmentROP Risk (G-ROP)SPEED Score (Dry Eye)SUN Uveitis GradingVertex Distance
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

LogMAR <-> Snellen

log
BetterVisual Acuity ScalePoorer
Snellen Equivalent
--/--
Excellent Vision
Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Standardization of visual acuity in clinical trials
Low vision assessment where Snellen charts lack resolution
Pediatric ophthalmology scoring
Calculating mean visual acuity across a population

How it Works

Visual Acuity Formulas

LogMAR = -log10(Decimal VA) Decimal VA = 20 / Snellen Denominator Snellen Denominator = 20 / (10^-LogMAR)

Interpretation

SnellenLogMARInterpretation
20/200.0Standard Vision
20/400.3UK Driving Limit
20/2001.0Legal Blindness (US)
20/20002.0Count Fingers

Clinical Pearls

LogMAR Advantages

Unlike Snellen, LogMAR provides a linear scale where each line represents a change of 0.1 log units. This allows for parametric statistical analysis and more accurate tracking of progression in low-vision patients.

The Evidence

Primary Reference

New design principles for visual acuity letter charts

Bailey IL et al. • Am J Optom Physiol Opt. 1976;53(11):740-5

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.